InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,278.80
(
0.33%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.42
(
1.12%
)
Bitcoin
61,496.35
(
1.12%
)
Post# of 252407
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119943
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 235452

Friday, 11/06/2020 6:28:04 AM

Friday, November 06, 2020 6:28:04 AM

Post# of 252407

Whatever biomarker and stopping criteria ASMB used clearly failed.

The stopping criterion was undetectable pgRNA in the blood, based on a proprietary, sensitive assay. However, undetectable pgRNA in the blood does not imply that viral replication in hepatocytes has ceased. ASMB uses a blood assay because liver biopsies are unduly invasive.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up